신생아 지속 폐동맥 고혈압에서 흡입 일산화질소 치료의 임상적 적용

키워드

참고문헌 (76)

1. Pepke-Zaba J, "Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension", Lancet, 338, pp.1173~1174 (1991)
2. Kinsella JP, "Low-dose inhalation nitric oxide in persistent pulmonary hypertension of the newborn", Lancet, 340, pp.819~820 (1992)
3. Roberts JD, "Inhaled nitric oxide in persistent pulmonary hypertension of the newborn", Lancet, 340, pp.818~819 (1992)
4. Trachsel D, "Oxygenation index predicts outcome in children with acute hypoxemic respiratory failure", Am J Respir Crit Care Med, 172, pp.206~211 (2005)
5. Bahrami KR, "ECMO for neonatal respiratory failure", Semin Perinatol, 29, pp.15~23 (2005)
6. Beck R, "Criteria for extracorporeal membrane oxygenation in a population of infants with persistent pulmonary hypertension of the newborn", J Pediatr Surg, 21, pp.297~302 (1986)
7. Elbourne D, "Extracorporeal membrane oxygenation for severe respiratory failure in newborn infants", Cochrane Database Syst Rev, pp.CD001340~ (2002)[DOI]
8. Ford JW, "Neonatal ECMO: Current controversies and trends", Neonatal Netw, 25, pp.229~238 (2006)
9. Kinsella JP, "Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn", J Pediatr, 131, pp.55~62 (1997)
10. Roberts JD, Jr, "Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group", N Engl J Med, 336, pp.605~610 (1997)
11. Wessel DL, "Improved oxygenation in a randomized trial of inhaled nitric oxide for persistent pulmonary hypertension of the newborn", Pediatrics, 100, pp.E7~ (1997)
12. Franco-Belgium Collaborative NO Trial Group, "Early compared with delayed inhaled nitric oxide in moderately hypoxaemic neonates with respiratory failure: a randomised controlled trial", Lancet, 354, pp.1066~1071 (1999)
13. Gonzalez A, "Randomized controlled trial of early compared with delayed use of inhaled nitric oxide in newborns with a moderate respiratory failure and pulmonary hypertension", J Perinatol, 30, pp.420~424 (2010)
14. Konduri GG, "A randomized trial of early versus standard inhaled nitric oxide therapy in term and near-term newborn infants with hypoxic respiratory failure", Pediatrics, 113, pp.559~564 (2004)
15. DiBlasi RM, "Evidence-based clinical practice guideline: inhaled nitric oxide for neonates with acute hypoxic respiratory failure", Respir Care, 55, pp.1717~1745 (2010)
16. Finer NN, "Nitric oxide for respiratory failure in infants born at or near term", Cochrane Database Syst Rev, pp.CD000399~ (2006)[DOI]
17. Kinsella JP, "Inhaled nitric oxide in the term newborn", Early Hum Dev, 84, pp.709~716 (2008)
18. Konduri GG, "Advances in the diagnosis and management of persistent pulmonary hypertension of the newborn", Pediatr Clin North Am, 56, pp.579~600 (2009)
19. Muraca MC, "Nitric oxide in neonatal hypoxemic respiratory failure", J Matern Fetal Neonatal Med, 25(Suppl 1), pp.47~50 (2012)
20. Nair J, "Update on PPHN: mechanisms and treatment", Semin Perinatol, 38, pp.78~91 (2014)
21. Peliowski A, "Inhaled nitric oxide use in newborns", Paediatr Child Health, 17, pp.95~100 (2012)
22. Soll RF, "Inhaled nitric oxide in the neonate", J Perinatol, 29(Suppl 2), pp.S63~67 (2009)
23. Teng RJ, "Persistent pulmonary hypertension of the newborn", J Formos Med Assoc, 112, pp.177~184 (2013)
24. Roberts JD, Jr., "Inhaled nitric oxide reverses pulmonary vasoconstriction in the hypoxic and acidotic newborn lamb", Circ Res, 72, pp.246~254 (1993)
25. Kinsella JP, "Hemo dynamic effects of exogenous nitric oxide in ovine transitional pulmonary circulation", Am J Physiol, 263, pp.H875~880 (1992)
26. Davidson D, "Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, double-masked, placebo-controlled, dose-response, multicenter study. The I-NO", PPHN Study Group, 1998, pp.101, 325~334
27. Neonatal Inhaled Nitric Oxide Study Group, "Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure", N Engl J Med, 336, pp.597~604 (1997)
28. Cornfield DN, "Randomized, controlled trial of low-dose inhaled nitric oxide in the treatment of term and near-term infants with respiratory failure and pulmonary hypertension", Pediatrics, 104, pp.1089~1094 (1999)
29. Finer NN, "Randomized, prospective study of low-dose versus high-dose inhaled nitric oxide in the neonate with hypoxic respiratory failure", Pediatrics, 108, pp.949~955 (2001)
30. Tworetzky W, "Inhaled nitric oxide in neonates with persistent pulmonary hypertension", Lancet, 357, pp.118~120 (2001)
31. Clark RH, "Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Oxide Research Group", N Engl J Med, 342, pp.469~474 (2000)
32. Christou H, "Inhaled nitric oxide reduces the need for extracorporeal membrane oxygenation in infants with persistent pulmonary hypertension of the newborn", Crit Care Med, 28, pp.3722~3727 (2000)
33. Barefield ES, "Inhaled nitric oxide in term infants with hypoxemic respiratory failure", J Pediatr, 129, pp.279~286 (1996)
34. Sadiq HF, "Inhaled nitric oxide in the treatment of moderate persistent pulmonary hypertension of the newborn: a randomized controlled, multicenter trial", J Perinatol, 23, pp.98~103 (2003)
35. Guthrie SO, "Initial dosing of inhaled nitric oxide in infants with hypoxic respiratory failure", J Perinatol, 24, pp.290~294 (2004)
36. Baquero H, "Oral sildenafil in infants with persistent pulmonary hypertension of the newborn: a pilot randomized blinded study", Pediatrics, 117, pp.1077~1083 (2006)
37. Vargas-Origel A, "The use of sildenafil in persistent pulmonary hypertension of the newborn", Am J Perinatol, 27, pp.225~230 (2010)
38. Bassler D, "Neonatal persistent pulmonary hypertension treated with milrinone: four case reports", Biol Neonate, 89, pp.1~5 (2006)
39. McNamara PJ, "Milrinone improves oxygenation in neonates with severe persistent pulmonary hypertension of the newborn", J Crit Care, 21, pp.217~222 (2006)
40. McNamara PJ, "Pharmacology of milrinone in neonates with persistent pulmonary hypertension of the newborn and suboptimal response to inhaled nitric oxide", Pediatr Crit Care Med, 14, pp.74~84 (2013)
41. Tzialla C, "Persistent pulmonary hypertension of the newborn refractory to inhaled nitric oxide-treated with milrinone: a case report", Turk J Pediatr, 52, pp.78~80 (2010)
42. Rao S, "Current and future therapeutic options for persistent pulmonary hypertension in the newborn", Expert Rev Cardiovasc Ther, 8, pp.845~862 (2010)
43. Kossel H, "Do we need new indications for ECMO in neonates pretreated with highfrequency ventilation and", or inhaled nitric oxide?, 2000, pp.26, 1489~1495
44. van Berkel S, "Adapted ECMO criteria for newborns with persistent pulmonary hypertension after inhaled nitric oxide and", or high-frequency oscillatory ventilation, 2013, pp.39, 1113~1120
45. Sokol GM, "Changes in arterial oxygen tension when weaning neonates from inhaled nitric oxide", Pediatr Pulmonol, 32, pp.14~19 (2001)
46. Goldman AP, "Four patterns of response to inhaled nitric oxide for persistent pulmonary hypertension of the newborn", Pediatrics, 98, pp.706~713 (1996)
47. Christenson J, "The incidence and pathogenesis of cardiopulmonary deterioration after abrupt withdrawal of inhaled nitric oxide", Am J Respir Crit Care Med, 161, pp.1443~1449 (2000)
48. Francoise M, "Hemodynamics and oxygenation changes induced by the discontinuation of lowdose inhalational nitric oxide in newborn infants", Intensive Care Med, 22, pp.477~481 (1996)
49. Lavoie A, "Life-threatening effects of discontinuing inhaled nitric oxide in severe respiratory failure", Am J Respir Crit Care Med, 153, pp.1985~1987 (1996)
50. Miller OI, "Rebound pulmonary hypertension on withdrawal from inhaled nitric oxide", Lancet, 346, pp.51~52 (1995)
51. Aly H, "Weaning strategy with inhaled nitric oxide treatment in persistent pulmonary hypertension of the newborn", Arch Dis Child Fetal Neonatal Ed, 76, pp.F118~122 (1997)
52. Atz AM, "Sildenafil ameliorates effects of inhaled nitric oxide withdrawal", Anesthesiology, 91, pp.307~310 (1999)
53. Behrends M, "Combination of sildenafil and bosentan for nitric oxide withdrawal", Eur J Anaesthesiol, 22, pp.155~157 (2005)
54. Buysse C, "The use of dipyridamole to wean from inhaled nitric oxide in congenital diaphragmatic hernia", J Pediatr Surg, 36, pp.1864~1865 (2001)
55. Ivy DD, "Dipyridamole attenuates rebound pulmonary hypertension after inhaled nitric oxide withdrawal in postoperative congenital heart disease", J Thorac Cardiovasc Surg, 115, pp.875~882 (1998)
56. Keller RL, "Treatment of rebound and chronic pulmonary hypertension with oral sildenafil in an infant with congenital diaphragmatic hernia", Pediatr Crit Care Med, 5, pp.184~187 (2004)
57. Saiki Y, "Successful weaning from inhaled nitric oxide using dipyridamole", Eur J Cardiothorac Surg, 24, pp.837~839 (2003)
58. Clark RH, "Prospective, randomized comparison of high-frequency oscillation and conventional ventilation in candidates for extracorporeal membrane oxygenation", J Pediatr, 124, pp.447~454 (1994)
59. Engle WA, "Controlled prospective randomized comparison of high-frequency jet ventilation and conventional ventilation in neonates with respiratory failure and persistent pulmonary hypertension", J Perinatol, 17, pp.3~9 (1997)
60. Hoehn T, "High-frequency ventilation augments the effect of inhaled nitric oxide in persistent pulmonary hypertension of the newborn", Eur Respir J, 11, pp.234~238 (1998)
61. Kinsella JP, "High-frequency oscillatory ventilation augments the response to inhaled nitric oxide in persistent pulmonary hypertension of the newborn: Nitric Oxide Study Group", Chest, 114, pp.100S~ (1998)
62. Lindwall R, "Delivery characteristics of a combined nitric oxide nasal continuous positive airway pressure system", Paediatr Anaesth, 12, pp.530~536 (2002)
63. Trevisanuto D, "Feasibility of nitric oxide administration by neonatal helmet-CPAP: a bench study", Paediatr Anaesth, 17, pp.851~855 (2007)
64. Nair J, "Successful treatment of a neonate with idiopathic persistent pulmonary hypertension with inhaled nitric oxide via nasal cannula without mechanical ventilation", AJP Rep, 2, pp.29~32 (2012)
65. Ambalavanan N, "Nitric oxide administration using an oxygen hood: a pilot trial", PLoS One, 4, pp.e4312~ (2009)
66. Young JD, "Laboratory evaluation of the I-NOvent nitric oxide delivery device", Br J Anaesth, 79, pp.398~401 (1997)
67. Hess D, "Toxicity and complications of inhaled nitric oxide", Respir Care Clin N Am, 3, pp.487~503 (1997)
68. Crow JP, "The role of peroxynitrite in nitric oxidemediated toxicity", Curr Top Microbiol Immunol, 196, pp.57~73 (1995)
69. Hallman M, "Pulmonary toxicity associated with nitric oxide in term infants with severe respiratory failure", J Pediatr, 132, pp.827~829 (1998)
70. Haddad IY, "Quantitation of nitrotyrosine levels in lung sections of patients and animals with acute lung injury", J Clin Invest, 94, pp.2407~2413 (1994)
71. Rasmussen TR, "Delayed effects of NO2 exposure on alveolar permeability and glutathione peroxidase in healthy humans", Am Rev Respir Dis, 146, pp.654~659 (1992)
72. Bylin G, "Effects of short-term exposure to ambient nitrogen dioxide concentrations on human bronchial reactivity and lung function", Eur J Respir Dis, 66, pp.205~217 (1985)
73. Phillips ML, "Assessment of medical personnel exposure to nitrogen oxides during inhaled nitric oxide treatment of neonatal and pediatric patients", Pediatrics, 104, pp.1095~1100 (1999)
74. Riddle EM, "Association of nitric oxide dose and methemoglobin levels in patients with congenital heart disease and pulmonary hypertension", Am J Cardiol, 90, pp.442~444 (2002)
75. Salguero KL, "Inhaled nitric oxide and methemoglobin in full-term infants with persistent pulmonary hypertension of the newborn", Pulm Pharmacol Ther, 15, pp.1~5 (2002)
76. Day RW, "A randomized, controlled study of the 1-hour and 24-hour effects of inhaled nitric oxide therapy in children with acute hypoxemic respiratory failure", Chest, 112, pp.1324~1331 (1997)

관련 논문AI추천